atezolizumab,talazoparib
roche,pfizer
['atezo', 'talazo', 'sclc']
the #oncoalerttoptweet day 2 #asco23 tweet by faculty s1929 trial atezo v atezo+talazoparib in es sclc shows pfs benefit (hr 0.7, p=0.05) for combo in slfn11+ sclc. slfn-11 ihc done completed in &gt;80%pts best, 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨